Gamida Cell stock price target cut to 6 from 8 at Oppenheimer
GMDADelisted Stock | USD 1.40 0.09 6.04% |
About 62% of Gamida Cell's investor base is looking to short. The analysis of current outlook of investing in Gamida Cell suggests that many traders are alarmed regarding Gamida Cell's prospects. The current market sentiment, together with Gamida Cell's historical and current headlines, can help investors time the market. In addition, many technical investors use Gamida Cell stock news signals to limit their universe of possible portfolio assets.
Gamida |
GMDA Complete Gamida Cell Ltd. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Read at marketwatch.com
Gamida Cell Fundamental Analysis
We analyze Gamida Cell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gamida Cell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gamida Cell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Gamida Cell is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Gamida Cell Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Gamida Cell stock to make a market-neutral strategy. Peer analysis of Gamida Cell could also be used in its relative valuation, which is a method of valuing Gamida Cell by comparing valuation metrics with similar companies.
Peers
Gamida Cell Related Equities
LXRX | Lexicon Pharmaceuticals | 11.69 | ||||
MCRB | Seres Therapeutics | 5.48 | ||||
INZY | Inozyme Pharma | 4.46 | ||||
IOVA | Iovance Biotherapeutics | 3.76 | ||||
ARDX | Ardelyx | 3.71 | ||||
DAWN | Day One | 2.85 | ||||
PLX | Protalix Biotherapeutics | 1.81 | ||||
TERN | Terns Pharmaceuticals | 1.40 | ||||
IBRX | Immunitybio | 1.19 | ||||
HOOK | Hookipa Pharma | 6.52 | ||||
XFOR | X4 Pharmaceuticals | 8.11 | ||||
BLRX | BioLineRx | 12.50 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in Gamida Stock
If you are still planning to invest in Gamida Cell check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gamida Cell's history and understand the potential risks before investing.
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Equity Valuation Check real value of public entities based on technical and fundamental data |